Aptatek Biosciences Wins “Best of the Best” at Year-End 1st Pitch Life Science Competition
January 06, 2020 09:35 ET
|
Mid Atlantic Bio Angels
NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Aptatek Biosciences (www.aptatek.com) which is developing a digital at-home health-maintenance system...
Ancilia, Inc. Wins “Best in Show” at New York City 1st Pitch Life Science Competition
November 12, 2019 09:35 ET
|
Mid Atlantic Bio Angels
NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Ancilia, Inc., which is developing therapies to specifically target the viral components of the gut...
Aptatek Biosciences Wins “Best in Show” at Philadelphia 1st Pitch Life Science Competition
November 11, 2019 09:35 ET
|
Mid Atlantic Bio Angels
PHILADELPHIA, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Aptatek Biosciences (www.aptatek.com) which is developing a digital at-home health-maintenance...
Applied Glycan Technologies, Inc. Wins “Best in Show” at 1st Pitch Life Science Competition
June 21, 2019 11:18 ET
|
Mid Atlantic Bio Angels
NEW YORK, June 21, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Applied Glycan Technologies, Inc. (http://www.appliedglycan.com), which is developing a topical...
BrachyThermix Wins “Best in Show” at 1st Pitch Life Science Philadelphia Competition
April 17, 2019 09:35 ET
|
Mid Atlantic Bio Angels
PHILADELPHIA, April 17, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that BrachyThermix, which has developed a medical device to improve outcomes of cancer surgery...
Handii 3D Wins “Best in Show” at 1st Pitch Life Science Competition
April 05, 2019 09:35 ET
|
Mid Atlantic Bio Angels
NEW YORK, April 05, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Handii 3D, which is developing hand and upper extremity splints for cerebral palsy patients, was...
Mid Atlantic Bio Angels Members and Its Closed-End Investment Pool II Makes Investment in Healionics Corporation
February 22, 2019 09:35 ET
|
Mid Atlantic Bio Angels
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that its previously announced, second closed-end investment pool (Pool II) solely funded by current, active...
Mid Atlantic Bio Angels Introduces “Sidecar Fund” for Non-Members to Participate in MABA Investments
January 29, 2019 09:35 ET
|
Mid Atlantic Bio Angels
NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announced today that it has formed a “sidecar” fund (https://sidecarfund.bioangels.net/) allowing accredited investors who...
Avisi Technologies, LLC Wins “Best of the Best” at Mid Atlantic Bio Angels’ Year-End 1st Pitch Life Science Competition
December 17, 2018 09:40 ET
|
Mid Atlantic Bio Angels
NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Avisi Technologies, LLC, which develops an eye implant for glaucoma treatment, was named “Best of the...
Mid Atlantic Bio Angels Invests in Salarius Pharmaceuticals
November 30, 2018 09:35 ET
|
Mid Atlantic Bio Angels
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in Houston-based Salarius Pharmaceuticals, which is developing epigenetic...